15 Results

People

  1. Levine
    Levine
  2. Koche
    Koche
  3. Abdel-Wahab
    Abdel-Wahab
  4. Bagish
    Bagish
  5. Berger
    Berger
  6. Cai
    Cai
  7. Castro
    Castro
  8. Chatila
    Chatila
  9. Chen
    Chen
  10. Chen
    Chen

Groups

  1. Department of Medicine (12)
  2. GSK Faculty (11)
  3. Center for Hematologic Malignancies (10)
  4. Hematologic Malignancies, Division of (8)
  5. Adult Leukemia (6)
  6. Executive Committee, Center for Hematologic Malignancies (6)
  7. Human Oncology and Pathogenesis Program (6)
  8. Sloan Kettering Institute Postdocs (6)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  10. MSK Grad Students (4)
  1. "dioxygenase"
Formats
  1. Journal Article (15)
Groups
  1. Department of Medicine (12)
  2. GSK Faculty (11)
  3. Center for Hematologic Malignancies (10)
  4. Hematologic Malignancies, Division of (8)
  5. Adult Leukemia (6)
  6. Executive Committee, Center for Hematologic Malignancies (6)

More Groups

People
  1. Ross Levine (4)
  2. Richard Koche (3)
  3. Omar Abdel-Wahab (2)
  4. Alexander Lewis (1)
  5. Alexander Penson (1)
  6. Ali Cihan (1)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (2)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Cancer Discovery (2)
  2. Nature (2)
  3. Cancer Research (1)
  4. Cell Reports (1)
  5. Cell Systems (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Cell Press (3)
  3. Nature Publishing Group (3)
  4. American Society for Clinical Investigation (1)
  5. Cold Spring Harbor Laboratory Press (1)
  6. Elsevier Inc. (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of TET2 affects proliferation and drug sensitivity through altered dynamics of cell-state transitions
    Journal Article

    Morinishi, L.; Kochanowski, K.; Levine, R. L.; Wu, L. F.; Altschuler, S. J.
    Cell Systems (2020)

    Fulltext@MSK | Save
  • TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells
    Journal Article

    Rasmussen, K. D.; Berest, I.; Keβler, S.; Nishimura, K.; Simón-Carrasco, L.; Vassiliou, G. S.; Pedersen, M. T.; Christensen, J.; Zaugg, J. B.; Helin, K.
    Genome Research (2019)

    Fulltext@MSK | Save
  • Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
    Journal Article

    Zhang, Q.; Zhao, K.; Shen, Q.; Han, Y.; Gu, Y.; Li, X.; Zhao, D.; Liu, Y.; Wang, C.; Zhang, X.; more...
    Nature (2015)

    Fulltext@MSK | Save
  • Overlapping requirements for Tet2 and Tet3 in normal development and hematopoietic stem cell emergence
    Journal Article

    Li, C.; Lan, Y.; Schwartz-Orbach, L.; Korol, E.; Tahiliani, M.; Evans, T.; Goll, M. G.
    Cell Reports (2015)

    Fulltext@MSK | Save
  • Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms
    Journal Article

    Abdel-Wahab, O.; Tefferi, A.; Levine, R. L.
    Hematology/Oncology Clinics of North America (2012)

    Fulltext@MSK | Save